Aujla, Amandeep, MD
Hartford HealthCare Medical Group

Amandeep Aujla, MD

Hematology / Oncology
4.8 / 5

Location Information

  • Hartford HealthCare Cancer Institute - Waterford
    196 Parkway South Suite 303
    Waterford, CT 06385


    Fax: 860.447.8961

  • Hartford HealthCare Cancer Institute at Backus Hospital
    326 Washington Street Suite APG-01
    Norwich, CT 06360


    Fax: 860.885.1022

  • Hartford HealthCare Cancer Institute - Norwich
    164 Otrobando Avenue
    Norwich, CT 06360


    Fax: 860.885.1022

About Amandeep Aujla, MD

  • Gender
  • Languages
    English, Hindi, Punjabi
    Providing the best care to our patients and their companions requires communicating in a way everyone understands. Interpreter services are available 24 hours a day, 7 days a week, 365 days a year. All spoken languages are available, as well as American Sign Language (AS/L)
  • Specialties
    Accepting New Patients

    Hematology / Oncology, Medical Oncology

  • Areas of Expertise
    Colorectal Cancer, Esophageal Cancer, Gastrointestinal Malignancies, Lung Cancer, Neuro-oncology, Prostate Cancer, Thoracic Cancers


  • FellowshipNew York Medical College

    InternshipNew York Medical College

    Medical SchoolGovernment Medical College Patiala

    ResidencyNew York Medical College


Other Reviews from Around the Web


Amandeep Aujla, MD, joined the Hartford Healthcare Cancer Institute in July 2020, and practices in the Norwich and Waterford offices. His practice is evolving and he sees patients with broad diagnoses of cancer with special interest in thoracic oncology, neuro-oncology and melanoma. After earning a medical degree in India, Dr. Aujla completed an internship, residency and fellowship in hematology and oncology at New York Medical College, where he also served as chief fellow in his third year. He has authored and participated in different projects focusing on breast cancer, kidney cancer, hematological malignancies, engraftment fever during stem cell transplantation and sickle cell disease. He also worked under the mentorship of Dr. Seah Lim, evaluating the role of targeting intestinal pathophysiology in decreasing vaso-occlusive crises in Sickle Cell Disease. The work led to the Food & Drug Administration designating Rifaxmin an orphan drug treatment for the disease.


Aetna, Anthem, BCBS Medicare, CarePartners of Connecticut, Cigna Healthcare, Colonial Cooperative Care, Community Health Network of Connecticut, Inc., Connecticare, Connecticare Commercial, Connecticare Medicare, Corvel, Coventry, Essence Healthcare, Evercare, First Health Group Corp., Focus, Harvard Pilgrim, Health Connecticut, Health Direct, Health New England, Healthy Connecticut, Multiplan, Northeast Health Direct, One Health Plan/ Great-West Healthcare, Oxford Health Plans, Prime Health Services, Private Health Care Systems, Inc., Senior Whole Health, United Healthcare, WellCare of Connecticut, Inc.
This information is subject to change at any time. Please check with your insurance provider before scheduling your appointment or receiving services to confirm they are a participating member of the Hartford HealthCare network.
Back to Top